Actuate Therapeutics is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib (formerly 9-ING-41), a small molecule that is des... Actuate Therapeutics is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). We are developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B. We believe that the blockade of GSK-3B signaling ultimately results in the death of the cancer cells and the regulation of anti-tumor immunity. We have exclusively licensed a portfolio of GSK-3 inhibitors developed in a collaboration between the University of Illinois-Chicago (UIC) and Northwestern University (NU). Show more
Actuate Corporation (NASDAQ: ACTU) (NASDAQ: BIRT), The people behind BIRT® and the leading open source Business Intelligence vendor, today announced that it has recognized...
Actuate Corporation (NASDAQ:BIRT), The people behind BIRT® and the leading open source Business Intelligence vendor, today reported that BIRT has now been downloaded over 10...
Actuate Corporation (NASDAQ: ACTU)(NASDAQ: BIRT), the people behind BIRT® and the leading open source Business Intelligence vendor, today announced financial results for the...
Actuate Corporation (NASDAQ:ACTU), The people behind BIRT® and the leading open source Business Intelligence (BI) vendor, today announced that BIRT Mobile is available for...
Actuate Corporation (NASDAQ:ACTU), The people behind BIRT® and the leading open source Business Intelligence vendor, today announced the highlights of its upcoming Actuate...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.35 | -3.64203954214 | 9.61 | 9.9499 | 7.5 | 12252 | 9.04040712 | CS |
4 | 0.78 | 9.19811320755 | 8.48 | 11.1261 | 7.5 | 28212 | 8.97702617 | CS |
12 | 0.5 | 5.70776255708 | 8.76 | 11.1261 | 6.27 | 52736 | 8.3422898 | CS |
26 | 4.26 | 85.2 | 5 | 11.1261 | 5 | 45577 | 8.16392733 | CS |
52 | 4.26 | 85.2 | 5 | 11.1261 | 5 | 22788 | 8.16392733 | CS |
156 | 4.26 | 85.2 | 5 | 11.1261 | 5 | 7596 | 8.16392733 | CS |
260 | 4.26 | 85.2 | 5 | 11.1261 | 5 | 5231 | 8.16392733 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.